CLASS II ONGOING Device recall · Reported 18 Mar 2026 · FDA Enforcement Report

IBA Proton Therapy System - Proteus recalled by Ion Beam Applications

Ion Beam Applications is recalling IBA Proton Therapy System - Proteus 235, distributed nationwide in the US. The recall was initiated on 3 Feb 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPROTEUS 235; UDI-DI: 05404013801138; Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)
Quantity recalled4 units (1 US, 3 OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1497-2026
FDA event ID
98364
Recalling firm
Ion Beam Applications, Ottignies-Louvain-La-Neuve, N/A
Classification
Class II
Status
Ongoing
Recall initiated
3 Feb 2026
FDA classified
6 Mar 2026
Reported
18 Mar 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

3 Feb 2026Recall initiated by company
6 Mar 2026Classified by FDA+31 days
18 Mar 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

IBA Proton Therapy System - PROTEUS 235

Where it was distributed

Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.

Nationwide Florida

Questions about this recall

Why was it recalled?

It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used.

Which lots are affected?

PROTEUS 235; UDI-DI: 05404013801138; Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)

Where was it sold?

Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,908